# Assessment of Abuse Potential of Drugs - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/assessment-of-abuse-potential-of-drugs/6c9a2ccd-021a-4f93-a97e-5444b6de4fef

> FDA guidance document: Assessment of Abuse Potential of Drugs. Issue date: January 18, 2017. Get complete insights and analysis.

---

## Details

- Title: Assessment of Abuse Potential of Drugs
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2017-01-18
- Last Changed: 2025-02-03
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2010-D-0026 ">FDA-2010-D-0026 </a>

## Related Documents

- [Botanical Drug Development: Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/botanical-drug-development-guidance-for-industry/bec78068-96c3-424e-b070-7b4ecfcfc8bf)
- [Good ANDA Submission Practices Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/good-anda-submission-practices-guidance-for-industry/c4f8f27a-3522-470b-8889-206366ebc0e7)
- [Nonclinical Evaluation of the Immunotoxic Potential of Pharmaceuticals](https://www.globalkeysolutions.net/guidances/guidance-document/nonclinical-evaluation-of-the-immunotoxic-potential-of-pharmaceuticals/160dff53-faf3-4095-b37e-414e108646cf)